Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Rocket Pharmaceuticals, Inc.    RCKT

ROCKET PHARMACEUTICALS, INC.

(RCKT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022
Capitalization1 6571 2331 590--
Entreprise Value (EV)1 6571 2331 3041 2901 402
P/E ratio -7,84x-14,4x-14,7x-12,8x-11,6x
Yield -----
Capitalization / Revenue ---171x96,8x
EV / Revenue ---139x85,3x
EV / EBITDA -9,28x-16,2x-13,5x-10,9x-10,7x
Price to Book --4,53x4,67x7,30x
Nbr of stocks (in thousands) 44 35354 17455 188--
Reference price (USD) 14,822,827,527,527,5
Last update 03/07/201903/05/202008/06/202008/06/202008/06/2020
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 ----9,3016,4
EBITDA1 --70,8-76,1-96,6-118-131
Operating profit (EBIT)1 -26,7-71,2-76,2-101-116-142
Operating Margin -----1 249%-865%
Pre-Tax Profit (EBT)1 --74,5-77,3-107-133-152
Net income1 --74,5-77,3-105-130-146
Net margin -----1 401%-889%
EPS2 --1,89-1,58-1,87-2,14-2,37
Dividend per Share2 ------
Last update 03/07/201803/07/201903/05/202008/17/202008/17/2020-
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 ------
Net Cash position1 ---286300188
Leverage (Debt / EBITDA) ---2,96x2,54x1,44x
Free Cash Flow1 -26,2-55,2-87,9-98,0-93,7-96,3
ROE (Net Profit / Equities) ----29,5%-35,3%-46,5%
Shareholders' equity1 ---358369314
ROA (Net Profit / Asset) ----25,7%-28,0%-37,4%
Assets1 ---411466390
Book Value Per Share2 ---6,075,893,77
Cash Flow per Share ------
Capex1 0,071,4523,34,703,603,44
Capex / Sales ----38,7%20,9%
Last update 03/07/201803/07/201903/05/202010/19/202010/19/202010/19/2020
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (USD)
1 589 954 727
Number of employees
79
Free-Float
91,0%
Free-Float capitalization (USD)
1 446 561 336
Avg. Exchange 20 sessions (USD)
8 699 678
Average Daily Capital Traded
0,55%
EPS & Dividend